Method for preparing multilayer medicine composite degradable biliary tract rack visible under X-ray
An x-ray and drug technology is applied in the field of multi-layer drug composite polymer material bile duct stent and its preparation, which can solve the problems of easy blockage of stent lumen and the like
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Examples
preparation example Construction
[0024] 1) Preparation of the main body of the stent: winding filaments of degradable polymer materials with drugs and imaging agents on a mold to form a stent;
[0025] 2) Select a series of polymer materials, the selection methods are as follows:
[0026] a) Use one of polylactic acid, copolymer of lactic acid and glycolic acid, polycaprolactide, polyβ-hydroxybutyrate valerate or polycaprolactone, and select 3 to 10 materials with different molecular weights , the largest molecular weight is 100,000 to 1,000,000 D / mol, and each molecular weight has a difference of 0.1 to 200,000 D / mol.
[0027] b) Select a copolymer of lactic acid and glycolic acid, the molecular weight of the selected material is 50,000 to 500,000; select 3 to 5 kinds of lactic acid monomer molar content, the maximum of which is 50% to 100%, and each content differs by 5% to 20% in turn %;
[0028] c) Choose one of chitosan, chitin, collagen, gelatin natural polymer, and mix it with polyethylene glycol wit...
Embodiment 1
[0036] (1) Add polycaprolactone to chloroform to form a solution with a mass volume concentration of 20% (g / ml), stir and fully dissolve. The molecular weight of PCL used is 300,000. Docetaxel was added into the solution to make the drug molar volume concentration 1 (mol / ml). Stir well.
[0037] (2) The solution is poured into the mold and volatilized at 0°C. Control the film thickness to 0.4mm. Sheets with a width of 2 mm were produced. The polymer sheet is wound on a certain mold and thermosetted at 100°C. The resulting shape is spiral.
[0038] (3) Prepare chloroform solutions of polycaprolactones with different molecular weights, the molecular weights are respectively: 1,000,000, 800,000, and 600,000. The mass volume concentration of the solution is 0.0001 (g / ml). The anti-inflammatory substance dexamethasone is added to make its mass volume concentration 0.2 (g / ml). Sodium iodide was added at a mass volume concentration of 0.2 g / ml, and an antineoplastic drug pacl...
Embodiment 2
[0041] (1) Add polycaprolactone to chloroform to form a solution with a mass volume concentration of 20% (g / ml), stir and fully dissolve. The molecular weight of PCL used is 300,000. Docetaxel was added into the solution to make the drug molar volume concentration 1 (mol / ml). Stir well.
[0042] (2) The solution is poured into the mold and volatilized at 0°C. Control the film thickness to 0.4mm. Sheets with a width of 2 mm were produced. The polymer sheet is wound on a certain mold and thermosetted at 100°C. The resulting shape is spiral.
[0043] (3) Configure chloroform solutions of polylactic acid with different molecular weights, the molecular weights are: 100,000, 99,000, 98,000, 97,000, 96,000, 95,000, 94,000, 93,000, 92,000, and 91,000. The mass volume concentration of the solution is 0.2 (g / ml).
[0044] (4) Dilute the suspension in (3) by 10ml / cm 2 The ratio of spraying and pouring on the sheet in (2) in sequence. After each spraying, air-dry and heat-treat a...
PUM
Property | Measurement | Unit |
---|---|---|
Thickness | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com